In 3802 mRCC patients, inpatient palliative care use have increased from 4.9% to 31.5% between 2008 and 2019. Admission to teaching hospitals or in the West is associated with higher inpatient palliative care rates. In consequence, regional disparities, as well as differences according to teaching hospital status represent targets to achieve comprehensive inpatient palliative coverage in mRCC patients receiving critical care therapy. Purpose: Temporal trends in and predictors of inpatient palliative care use in patients with metastatic renal cell carcinoma (mRCC) undergoing critical care therapy are unknown. Methods: Relying on the National Inpatient Sample (2008-2019), we identified mRCC patients undergoing critical care therapy, namely invasive mechanical ventilation, percutaneous endoscopic gastrostomy tube insertion, dialysis for acute kidney failure, total parenteral nutrition, or tracheostomy. Estimated annual percentage changes (EAPC) analyses and multivariable logistic regression models addressed inpatient palliative care use. Results: Of 3802 mRCC patients undergoing critical care therapy, 817 (21.5%) received inpatient palliative care. Overall, inpatient palliative care use increased from 4.9% to 31.5% between 2008 and 2019 (EAPC + 9.2%). In subgroup analyses, the highest increase in inpatient palliative care use was observed in the Midwest (EAPC: + 11.9%), in the South (EAPC + 10.4%), and in teaching hospitals (EAPC + 9.0%; all P <_ .004). In logistic regression models, teaching hospital status (odds ratio [OR] 1.41) and contemporar y year inter val (OR 2.12; all P < .001) independently predicted higher inpatient palliative care rates. Conversely, hospital admission in the Northeast (OR 0.53) or in the South (OR 0.79; all P <_ .03) was associated with lower inpatient palliative care rates than in the West. Conclusion: In mRCC patients, inpatient palliative care rates have improved over time, with the highest increase in hospitals in the Midwest and in the South. Moreover, admission to teaching hospitals or in the West is associated with higher inpatient palliative care rates. In consequence, regional disparities, as well as differences according to teaching hospital status represent targets to achieve comprehensive inpatient palliative care coverage in mRCC patients receiving critical care therapy.
Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care Therapy / C. Siech, S. Morra, L. Scheipner, A. Baudo, M. de Angelis, L.M.I. Jannello, N. Touma, J.A. Goyal, Z. Tian, F. Saad, S.F. Shariat, N. Longo, L. Carmignani, O. de Cobelli, S. Ahyai, A. Briganti, C. Cano Garcia, L.A. Kluth, F.K.H. Chun, P.I. Karakiewicz. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1558-7673. - 23:1(2025), pp. 1-8. [10.1016/j.clgc.2024.102269]
Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care Therapy
A. Baudo;L.M.I. Jannello;L. Carmignani;O. De Cobelli;
2025
Abstract
In 3802 mRCC patients, inpatient palliative care use have increased from 4.9% to 31.5% between 2008 and 2019. Admission to teaching hospitals or in the West is associated with higher inpatient palliative care rates. In consequence, regional disparities, as well as differences according to teaching hospital status represent targets to achieve comprehensive inpatient palliative coverage in mRCC patients receiving critical care therapy. Purpose: Temporal trends in and predictors of inpatient palliative care use in patients with metastatic renal cell carcinoma (mRCC) undergoing critical care therapy are unknown. Methods: Relying on the National Inpatient Sample (2008-2019), we identified mRCC patients undergoing critical care therapy, namely invasive mechanical ventilation, percutaneous endoscopic gastrostomy tube insertion, dialysis for acute kidney failure, total parenteral nutrition, or tracheostomy. Estimated annual percentage changes (EAPC) analyses and multivariable logistic regression models addressed inpatient palliative care use. Results: Of 3802 mRCC patients undergoing critical care therapy, 817 (21.5%) received inpatient palliative care. Overall, inpatient palliative care use increased from 4.9% to 31.5% between 2008 and 2019 (EAPC + 9.2%). In subgroup analyses, the highest increase in inpatient palliative care use was observed in the Midwest (EAPC: + 11.9%), in the South (EAPC + 10.4%), and in teaching hospitals (EAPC + 9.0%; all P <_ .004). In logistic regression models, teaching hospital status (odds ratio [OR] 1.41) and contemporar y year inter val (OR 2.12; all P < .001) independently predicted higher inpatient palliative care rates. Conversely, hospital admission in the Northeast (OR 0.53) or in the South (OR 0.79; all P <_ .03) was associated with lower inpatient palliative care rates than in the West. Conclusion: In mRCC patients, inpatient palliative care rates have improved over time, with the highest increase in hospitals in the Midwest and in the South. Moreover, admission to teaching hospitals or in the West is associated with higher inpatient palliative care rates. In consequence, regional disparities, as well as differences according to teaching hospital status represent targets to achieve comprehensive inpatient palliative care coverage in mRCC patients receiving critical care therapy.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1558767324002398-main.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
612.46 kB
Formato
Adobe PDF
|
612.46 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




